New FDA approved Alternative to Hip Replacement -- MEDICA - World Forum for Medicine

The novel system developed at the Baylor University Medical Center at Dallas is the first total hip resurfacing technique and implant approved for use by the Food & Drug Administration (FDA), the researchers say. This bone-conserving approach preserves more of the patient’s natural bone structure and stability by covering the joint’s surfaces with an all-metal implant. The approach reduces post-operative risks such as joint dislocation and inaccurate leg length - two of the leading causes of implant failure after total hip replacements.

“This procedure is intended for younger, active patients who live a non-sedentary lifestyle who may be suffering from hip pain due to osteoarthritis, dysplasia or avascular necrosis,” says Kurt Rathjen, M.D., orthopaedic surgeon on the medical staff at Baylor Dallas trained to perform the new hip resurfacing procedure. “For these people, a total hip replacement may not be their best option.”

“There’s a perception that the audience for hip replacement surgery is elderly, but that’s really not the case anymore,” says Richard Schubert, M.D., orthopaedic surgeon on the medical staff at Baylor Dallas also trained to perform the hip resurfacing procedure. “We’re seeing patients in their 40s and 50s who are already experiencing severe osteoarthritis that limits their daily activities.”

Rathjen and Schubert say that after undergoing hip resurfacing most patients should be able to return to their normal physical activities after the first year. “Hip resurfacing allows the patient to return to a higher level of activity than with traditional total hip replacements,” adds Schubert.; Source: Baylor Health Care System System